Latest Breaking News On - Spondyloarthritis research consortium of canada - Page 1 : comparemela.com

Upadacitinib Improves Enthesitis Among Patients with Psoriatic Arthritis

The findings of this post-hoc analysis suggest a need for follow-up studies assessing and comparing JAK inhibition impact on the development of enthesitis.

Fabrizio cantiniToscana centroSpondyloarthritis research consortium of canadaLeeds enthesitis indexSpondyloarthritis research consortiumRheum disPsoriatic arthritis

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSpondyloarthritis research consortium of canadaTreatment networkRheum disOpin rheumatolAmerican collegeSpondylitis associationSpondyloarthritis researchRev rheumatolResearch consortiumSpondylitis disease activity scoreEnglj med

Study: Don t Assume Spinal Findings on MRI Signify Spondyloarthritis

Many healthy people also show sacroiliac and spine lesions

Thomas rensonJohn geverSpondyloarthritis research consortium of canadaGhent university hospitalAssessment of spondyloarthritis international societySpondyloarthritis research consortiumSpondyloarthritis international societyManaging editor

Upadacitinib Effective Against Nonradiographic AxSpA

The JAK inhibitor was effective and safe for patients with rheumatologist-diagnosed axial spondyloarthritis that did not meet radiographic criteria.

New yorkUnited statesSpondyloarthritis research consortium of canadaEuropean alliance of associationsCharite universityGhent universityFilip vanBath ankylosing spondylitis functional indexAnkylosing spondylitis disease activity scoreLow disease activityAnkylosing spondylitis qualityResearch consortiumMedscape medical newsOint inflammationPain managementPain management

AbbVie (ABBV) Presents Positive Phase 3 SELECT-AXIS 2 Trials of Upadacitinib Results at EULAR 2022

AbbVie (ABBV) Presents Positive Phase 3 SELECT-AXIS 2 Trials of Upadacitinib Results at EULAR 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Neil gallagherSpondyloarthritis research consortium of canadaUniversity hospital of ghentDepartment of rheumatologyEuropean medicines agencyDrug administrationBath ankylosing spondylitis functional indexAnkylosing spondylitis disease activity scoreLow disease activityAnkylosing spondylitis qualityResearch consortiumFilip vanUniversity hospitalGhent university